A woman receives a booster dose of the Moderna coronavirus disease (COVID-19) vaccine at a vaccination centre in Antwerp, Belgium, February 1, 2022.
Johanna Geron | Reuters
Proverbs 29:2 When the righteous thrive, the people rejoice; when the wicked rule, the people groan.
Important Takeaways:
- Universal flu vaccine based on mRNA tech to be tested by National Institutes of Health
- NIH is enrolling patients in an early-stage clinical trial to test a universal flu vaccine based on mRNA technology.
- The technology is behind Moderna’s and Pfizer’s widely used Covid vaccines.
- Scientists hope the vaccine will protect against a wide variety of flu strains and provide long-term immunity so people do not have to receive a shot every year.
- The study will also include participants who receive a quadrivalent flu vaccine, which protects against four strains of the virus, to compare the experimental universal shot to those currently on the market.
Read the original article by clicking here.
